Chronic Constipation Epidemiology Summary

• According to DelveInsight’s analysis, the total prevalent cases of Chronic Constipation were ~XXXX in the 7MM (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
• Chronic constipation is highly prevalent in countries due to aging populations, sedentary lifestyles, dietary changes, increasing prevalence of gastrointestinal and metabolic disorders, and greater awareness and diagnosis of bowel dysfunction among elderly individuals.
• Females experience a higher burden of chronic constipation compared to males. This disparity is largely attributed to hormonal influences, slower gastrointestinal transit, pregnancy-related factors, pelvic floor dysfunction, and higher susceptibility to functional gastrointestinal disorders.
• The prevalence of chronic constipation varies considerably depending on the diagnostic criteria used, including Rome IV criteria, stool frequency assessment, and self-reported symptoms. This highlights the impact of differing diagnostic definitions and clinical assessment methods on reported disease prevalence across regions and populations.
• The rising prevalence of aging populations, sedentary lifestyles, low-fiber dietary habits, metabolic disorders, neurological conditions, and medication-associated bowel dysfunction is expected to sustain the global burden of chronic constipation over the next decade. Strengthening early diagnosis, improving long-term disease management, increasing awareness, and developing effective targeted therapies will remain key determinants of future trends.

Chronic Constipation Epidemiology Forecast in the 7MM

• 2025 Prevalent Cases of Chronic Constipation: ~XXXX
• 2036 Projected Prevalent Cases of Chronic Constipation: ~XXXX
• Chronic Constipation Growth Rate (2026–2036): ~XX% CAGR

DelveInsight's ‘Chronic Constipation Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Chronic Constipation, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan.

Chronic Constipation Understanding and Diagnosis Algorithm

Chronic Constipation Overview and Diagnosis

Chronic constipation is a common gastrointestinal disorder characterized by infrequent bowel movements, difficulty passing stools, or a sensation of incomplete evacuation persisting for several weeks or longer. The condition can range from mild to severe and is often associated with symptoms such as abdominal discomfort, bloating, hard stools, and excessive straining during defecation. Chronic constipation may result from inadequate dietary fiber intake, dehydration, sedentary lifestyle, medication use, or underlying neurological and gastrointestinal disorders. Diagnosis is primarily based on clinical evaluation and symptom history.

Chronic constipation is diagnosed through medical history, physical examination, and assessment of bowel habits and symptoms. Physicians evaluate stool frequency, stool consistency, difficulty during defecation, sensation of incomplete evacuation, and associated symptoms such as abdominal discomfort or bloating. Diagnostic tests may include blood tests to rule out metabolic or hormonal disorders, stool tests, and imaging studies when necessary. In patients with persistent or severe symptoms, specialized investigations such as colonoscopy, anorectal manometry, balloon expulsion testing, or colonic transit studies may be performed to identify underlying structural or functional abnormalities.

Note: Further details are provided in the report...

Chronic Constipation Epidemiology

Key Findings from Chronic Constipation Epidemiological Analysis and Forecast

• Chronic Constipation accounts for more than 95% of cases of constipation in healthy children aged one year and older.
• Among the 7MM, the United States accounted for the highest number of prevalent cases of Chronic Constipation in 2025.
• Chronic Constipation is particularly common among preschool-aged children.
• According to findings, the prevalence of chronic constipation was reported to be 5.5% in the US, according to the Rome III criteria, and it was found to be 2.1% based on medical consultations in Japan.
• Chronic Constipation demonstrates a clear female predominance, with women experiencing the condition at roughly twice the rate of men across most demographic studies.

Scope of the Chronic Constipation Epidemiology Report

• The report covers a segment of an executive summary, a descriptive overview of chronic constipation, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Chronic Constipation Epidemiology Report Insights

• Chronic Constipation Patient Population Forecast

Chronic Constipation Epidemiology Report Key Strengths

• Epidemiology based (epi based) Bottom up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

Explore DelveInsight's Chronic Constipation Market Insight, Epidemiology and Market Forecast – 2036 to uncover emerging therapies, market trends, and growth opportunities.

FAQs

• What are the disease risks, burdens, and unmet needs of chronic constipation? What will be the growth opportunities across the 7MM concerning the patient population with chronic constipation?
• What is the historical and forecasted chronic constipation patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy Chronic Constipation Epidemiology Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.